Navigation Links
Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
Date:10/28/2011

NEW YORK, Oct. 28, 2011 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced that it will host a conference call and webcast to discuss its recent corporate developments and update its progress on Monday, November 7, 2011 at 4:30 p.m. ET.  Eamonn Hobbs, President and Chief Executive Officer will host the call.

The dial-in number for the conference call is 800-322-5044 for domestic participants and 617-614-4927 for international participants, both using passcode 65515511.

To access the live webcast of the meeting, go to Delcath's website at www.delcath.com. A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 65413528. An archived webcast will also be available at www.delcath.com.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for c
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Schedules Delcath Pre-New Drug Application Meeting Date
2. Delcath Announces Completion of Regulatory Notification Process in New Zealand
3. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
4. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
5. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
6. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
7. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
8. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
9. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
10. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
11. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Trinidad and Tobago , July 25, 2014 ... the Trinidad & Tobago Ministry of Health approved ... therapy that significantly increases the cure rate from ... infected with the genotype 1 virus. Telaprevir is ... the trade brand INCIVO®. Photo - ...
(Date:7/25/2014)... 25, 2014 According to a ... and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, ... Growth, Trends and Forecast (Value and Volume), 2013 - ... 19.99 billion in 2012 and is expected to grow ... to reach USD 32.24 billion in 2019. ...
(Date:7/25/2014)... BERWYN, Pa. , July 25, 2014  AMETEK, ... appointment of Kurtis L. Goos as Vice ... Engineered Materials, Interconnects and Packaging (EMIP) Division. ... has extensive general management and business development experience, especially ... to make important contributions to the continued growth and ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2
... Features Give Molecular Laboratories Increased Efficiencies and Flexibility ... and is Unique in its Ability to Detect and ... Measure All Known Strains of HIV-1, ... ),has received a supplemental Premarket Approval from the U.S. Food and ...
... Solvay Pharmaceuticals, Inc. and,Wyeth Pharmaceuticals, a division of ... an action letter from the U.S. Food and Drug ... for bifeprunox, an,atypical antipsychotic that was reviewed for the ... stable adult patients. The,Agency stated that the drug was ...
Cached Medicine Technology:Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 2Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 3Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 5Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 6Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia 2Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia 3
(Date:7/28/2014)... DC (PRWEB) July 28, 2014 As ... many are looking to private exchanges. “Private Exchange ... August 6 webinar from Atlantic Information Services, will provide ... private exchange strategies for the future. , Barbara Gniewek, ... PwC with extensive experience in the private exchange sector ...
(Date:7/28/2014)... According to the Heartburn No More PDF review recently updated ... people get rid of acid reflux naturally. This ... and acid reflux. In addition, inside this book, people will ... for reflux disease. , Vkool informs in its review ... of reflux disease naturally without medications. The book also instructs ...
(Date:7/28/2014)... 28, 2014 Building a sense of ... important. Where personal outdoor space is not possible, ... enjoy fun and exercise outside is important. That’s ... in quality commercial playground equipment from APCPLAY. , Old ... Midlothian, Virginia. It is an historic tourist location of ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Greta Pontarelli, 63, ... the Masters Champion title at the World Pole Sports Championships ... obstacle for this athlete. She is the only U.S. competitor ... the International Pole Sports Federation (IPSF). Over 150 athletes ranging ... took part in the competition. Pontarelli scored first place in ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dr. Alan Xenakis, ... “DOC X MD Funny Feelings.” The new book, DOC ... Feelings in a unique story telling style with humor and ... and motivational. The reader will find answers to those age-old ... running water make people pee? Why do mosquitoes bite some ...
Breaking Medicine News(10 mins):Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Playground Creates Outdoor Fun for Community at Old Buckingham Station at Midlothian Village (VA) with APCPLAY© 2Health News:Inspiring Senior Athlete Lands Third World Title in One Year 2Health News:New Book by Alan P. Xenakis, MD Reveals Mind and Body Mysteries 2
... gene determines people’s sensitivity to pain.In the study conducted ... prevented by blocking the expression of that particular gene ... a breakthrough in development of new painkillers. ... them had the genetic variant that protects them from ...
... pills for easier swallowing can be dangerous as the tablet’s ... body and crushing could cause serious side effects. ... said, “People can opt to take drugs in patch, liquid ... 60% of the older people. Studies have revealed that tablets ...
... at National University of Singapore recently by researchers, reported ... edition, to study the tangible benefits of curries commonly ... regular consumption of meals which are accompanied by a ... the brain which is often indelibly associated with aging. ...
... Butler, a pioneering plastic and reconstructive surgeon has been ... ethics committee of the Royal Free Hospital, London to ... ,However the Royal College of Surgeons has called for ... transplantation. ,The surgery promises to transform the lives ...
... Sanofi-Aventis' Accomplia (rimonabant), a new drug for treatment of obesity, ... cardiac problems// in people with diabetes type 2. The research was ... in Europe and south and North America. ,Some of them ... others were treated with a placebo, for a 1 year period. ...
... dengue in the capital Thursday taking the death toll in India ... a considerable// fall in the number of fresh cases. ... days with only 74 cases being reported Wednesday across the country, ... ,Officials said it was easily one of the ...
Cached Medicine News:Health News:Gene determines pain threshold... 2Health News:Spices in curries spruce up aging minds 2Health News:Green Signal given to Full-Face Transplants 2Health News:Green Signal given to Full-Face Transplants 3
Inquire...
... MicroAire Power Assisted Lipoplasty Device uses a 2-mm ... facilitate the movement of the cannula in tissue. ... with more fibrous tissue. That makes the lipoplasty ... will ease your mind to learn that the ...
... 1/3 hp. 0-8 scfm/0-29.8 in.hg.@sea level. Incredibly ... to 4 collection canister systems at one ... changes during the procedure. Standard canister set-up ... filters not included). UL, c-UL and CE ...
... new term being used today to describe the nature ... that may have been used in silicone implants in ... is not new technology cohesive is simply a ... together nature of the gel. All of Mentor silicone ...
Medicine Products: